References
- Ahmed, S., et al., 2014. Arsenic exposure and cell-mediated immunity in pre-school children in rural Bangladesh. Toxicological Sciences, 141(1), 166–175.
- Ammer, E., et al., 2015. The anti-obesity drug orlistat reveals anti-viral activity. Medical Microbiology and Immunology, 204(6), 635–645.
- Argos, M., et al., 2010. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. The Lancet, 376(9737), 252–258.
- Bello, M., et al., 2017. Molecular recognition between pancreatic lipase and natural and synthetic inhibitors. International Journal of Biological Macromolecules, 98, 855–868.
- Biswas, R., et al., 2008. Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Human & Experimental Toxicology, 27(5), 381–386.
- Bolt, A.M., Douglas, R.M., and Klimecki, W.T., 2010. Arsenite exposure in human lymphoblastoid cell lines induces autophagy and coordinated induction of lysosomal genes. Toxicology Letters, 199(2), 153–159.
- Camell, C.D., et al., 2017. Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing. Nature, 550(7674), 119–123.
- Chen, H., et al., 2017. Orlistat response to missense mutations in lipoprotein lipase. Biotechnology and Applied Biochemistry, 64(4), 464–470.
- Cooper, K.L., et al., 2013. Reduction of arsenite-enhanced ultraviolet radiation-induced DNA damage by supplemental zinc. Toxicology and Applied Pharmacology, 269(2), 81–88.
- Daigneault, M., et al., 2010. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One, 5(1), e8668.
- Ellrichmann, M., et al., 2008. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations. The Journal of Clinical Endocrinology & Metabolism, 93(10), 3995–3998.
- Ezeh, P.C., et al., 2014. Arsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivo. PLoS One, 9(4), e93920.
- Goeritzer, M., et al., 2014. Deletion of CGI-58 or adipose triglyceride lipase differently affects macrophage function and atherosclerosis. Journal of Lipid Research, 55(12), 2562–2575.
- Gutgsell, A.R., et al., 2019. Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition. Journal of Biological Chemistry, 294(8), 2678–2689.
- Jung, S.B., et al., 2018. Reduced oxidative capacity in macrophages results in systemic insulin resistance. Nature Communications, 9(1), 1551.
- Kawashima, R.L. and Medh, J.D., 2014. Down-regulation of lipoprotein lipase increases ABCA1-mediated cholesterol efflux in THP-1 macrophages. Biochemical and Biophysical Research Communications, 2450(4), 1416–1421.
- Li, B., et al., 2019. Resistin up-regulates LPL expression through the PPARγ-dependent PI3K/AKT signaling pathway impacting lipid accumulation in RAW264.7 macrophages. Cytokine, 119, 168–174.
- Meyers, N.L., et al., 2017. Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition. Journal of Lipid Research, 58(5), 840–852.
- Mosser, D.M. and Edwards, J.P., 2008. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology, 8(12), 958–969.
- Olszanecka-Glinianowicz, M., et al., 2013. Long-term inhibition of intestinal lipase by orlistat improves release of gut hormones increasing satiety in obese women. Pharmacological Reports, 65(3), 666–671.
- Paulmurugan, R., et al., 2016. Folate receptor-targeted polymeric micellar nanocarriers for delivery of orlistat as a repurposed drug against triple-negative breast cancer. Molecular Cancer Therapeutics, 15(2), 221–231.
- Schuhmacher-Wolz, U., et al., 2009. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Critical Reviews in Toxicology, 39, 271–298.
- Shettar, V., Patel, S., and Kidambi, S., 2017. Epidemiology of obesity and pharmacologic treatment options. Nutrition in Clinical Practice, 32(4), 441–462.
- Soria, E.A., et al., 2017. Immunotoxicological effects of arsenic bioaccumulation on spatial metallomics and cellular enzyme response in the spleen of male Wistar rats after oral intake. Toxicology Letters, 266, 65–73.
- Soto-Peña, G.A., et al., 2006. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. The FASEB Journal, 20(6), 779–781.
- Tan, X., et al., 2014. ATP-binding cassette transporter A1 (ABCA1) promotes arsenic tolerance in human cells by reducing cellular arsenic accumulation. Clinical and Experimental Pharmacology and Physiology, 41(4), 287–294.
- Thyagarajan, N., et al., 2017. Transcriptomic analysis of THP-1 macrophages exposed to lipoprotein hydrolysis products generated by lipoprotein lipase. Lipids, 52(3), 189–205.
- Wynn, T.A., Chawla, A., and Pollard, J.W., 2013. Macrophage biology in development, homeostasis and disease. Nature, 496(7446), 445–455.
- Xu, H., et al., 2017. Efflux transporters regulate arsenite-induced genotoxicity in double negative and double positive T cells. Toxicological Sciences, 158(1), 127–139.
- Xu, H., et al., 2016a. Environmentally-relevant concentrations of arsenite induce dose-dependent differential genotoxicity through poly(ADP-ribose) polymerase (PARP) inhibition and oxidative stress in mouse thymus cells. Toxicological Sciences, 149(1), 31–41.
- Xu, H., et al., 2016b. Differential sensitivities of bone marrow, spleen and thymus to genotoxicity induced by environmentally relevant concentrations of arsenite. Toxicology Letters, 262, 55–61.
- Xu, H., Wang, X., and Burchiel, S.W., 2018a. Toxicity of environmentally-relevant concentrations of arsenic on developing T lymphocyte. Environmental Toxicology and Pharmacology, 62, 107–113.
- Xu, H., Wang, X., and Wang, W., 2018b. Functional suppression of macrophages derived from THP-1 cells by environmentally-relevant concentrations of arsenite. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 214, 36–42.
- Xu, H., Wang, X., and Wang, W., 2018c. Monomethylarsonous acid: induction of DNA damage and oxidative stress in mouse natural killer cells at environmentally-relevant concentrations. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 832–833, 1–6.
- Yan, C., et al., 2006. Macrophage-specific expression of human lysosomal acid lipase corrects inflammation and pathogenic phenotypes in lal–/– mice. The American Journal of Pathology, 169(3), 916–926.
- You, B.J., et al., 2019. Orlistat displays antitumor activity and enhances the efficacy of paclitaxel in human hepatoma Hep3B cells. Chemical Research in Toxicology, 32(2), 255–264.
- Zhi, J., et al., 1995. Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. The Journal of Clinical Pharmacology, 35(11), 1103–1108.
- Zhou, T., et al., 2019. ABCA1 is coordinated with ABCB1 in the arsenic-resistance of human cells. Applied Biochemistry and Biotechnology, 187(1), 365–377.